AFC Gamma Expands Existing Senior Secured Credit Facilities With Three Existing Borrowers
March 7, 2022
Ryan Allway March 7th, 2022 News, Top News Supporting Continued Growth of Three Existing Borrowers: Verano, Nature’s Medicines and Natrabis AFC Gamma Commits $46.9 Million Under Expanded Credit Facilities WEST PALM BEACH, Fla., March 07, 2022 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today announced it has... Read more
Ryan Allway March 4th, 2022 Psychedelics, Top News VANCOUVER, British Columbia, March 04, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”), has entered into an agreement with the... Read more
Ryan Allway March 4th, 2022 News, Top News DENVER , March 4, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”) — a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products — announced today that it has closed its acquisition of an existing... Read more
Ryan Allway March 3rd, 2022 News, Top News LOS ANGELES and DESERT HOT SPRINGS, Calif., March 03, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based cannabiotech company, is providing an update on progress with the Company’s previously announced... Read more
Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affairs Canada for Reactivation Program
March 3, 2022
Ryan Allway March 3rd, 2022 Psychedelics, Top News The Company’s Receipt of Approval for the Multidisciplinary “Reactivation” Program Designed by its Wholly Owned Subsidiary is a Major Milestone That is Expected to Benefit Veterans and First Responders for the Foreseeable Future VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE)... Read more
Ryan Allway March 3rd, 2022 Psychedelics, Top News MELBOURNE, Australia, March 3, 2022 /PRNewswire/ — Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs, today announced it has executed a license agreement with... Read more
Ryan Allway March 3rd, 2022 News, Top News CHARLOTTE, N.C., March 03, 2022–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840... Read more
Ryan Allway March 3rd, 2022 News, Top News CLOVERDALE, CA / ACCESSWIRE / March 3, 2022 / Cann American Corp. (OTC Pink:CNNA), the “Company”, a holding company building a diverse portfolio of intellectual property and assets in the legal cannabis and hemp industries, is pleased to announce the cancellation of... Read more
VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) (“NeonMind” or the “Company“), an integrated drug development and wellness company focused on bringing innovative psychedelic-based treatments to people suffering from obesity and mental health disorders, announced today a strategic partnership with BioScript Solutions, a Canadian leader... Read more
San Diego, Calif, March 03, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has entered into an agreement with Novotech Health Holdings (“Novotech”), a leading full-service... Read more
